After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
RAPT Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of RAPT Therapeutics Inc is $308.91M. A total of 0.83 million shares were traded on the day, compared to an average of 1.05M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, RAPT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 7 BUYs and 4 SELLs from insiders. Insiders purchased 6,840 shares during that period but sold 15,000.
In the most recent transaction, Brockstedt Dirk G. sold 898 shares of RAPT for 22.78 per share on Jan 05. After the transaction, the CHIEF SCIENTIFIC OFFICER now owns 27,820 company shares. In a previous transaction on Dec 21, HO WILLIAM sold 2,500 shares at 21.68 per share. RAPT shares that Chief Medical Officer owns now total 15,020.
Among the insiders who sold shares, HO WILLIAM disposed of 1,500 shares on Nov 28 at a per-share price of $13.72. This resulted in the Chief Medical Officer holding 17,520 shares of RAPT after the transaction. In another insider transaction, HO WILLIAM sold 2,500 shares at $15.77 per share on Oct 03. Company shares held by the Chief Medical Officer now total 18,789.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, RAPT has a high of $31.45 and a low of $6.86.
As of this writing, RAPT has an earnings estimate of -$0.86 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$0.79 per share and a lower estimate of -$0.92. The company reported an EPS of -$0.66 in the last quarter, which was 15.40% higher than expectations of -$0.78.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RAPT’s latest balance sheet shows that the firm has $189.65M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $9.60M in liabilities at the time. Its Book Value Per Share was $5.03, while its Total Shareholder’s Equity was $186.38M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RAPT is Buy with a score of 4.17.
